Cerebral D2 and 5-HT2 receptor occupancy in schizophrenic patients treated with olanzapine or clozapine

Rosa Maria Moresco, Roberto Cavallaro, Cristina Messa, Daniele Bravi, Clara Gobbo, Laura Galli, Giovanni Lucignani, Cristina Colombo, Giovanna Rizzo, Isabella Velonà, Enrico Smeraldi, Ferruccio Fazio

Research output: Contribution to journalArticle

Abstract

We report the results of a double-blind, randomized prospective trial on D2 and 5-HT2 receptor occupancy and the clinical effects of olanzapine versus clozapine in a sample of neuroleptic-refractory schizophrenic patients. Receptor occupancy was evaluated in different cortical areas and in basal ganglia using [18F]fluoro-ethyl-spiperone ([ 18F]FESP) and positron emission tomography (PET). A total of 15 neuroleptic-free patients completed the study undergoing a baseline and a post-treatment PET scan (olanzapine, nine patients, one female; clozapine, six patients, three female) 8 weeks after starting treatment. PET data were analysed both by regions of interest and on a voxel-by-voxel basis using Statistical Parametric Mapping (SPM96). Olanzapine and clozapine induced a similar and significant inhibition of [18F]FESP binding index in the cortex. In the basal ganglia, receptor occupancy was significantly higher with olanzapine than with clozapine (p = 0.0018). By contrast, no differences in receptor occupancy were detected at the level of the pituitary gland. Clinical outcomes, in particular a full extrapyramidal tolerability, were similar. In this sample of neuroleptic-refractory schizophrenic patients, olanzapine and clozapine showed a different pattern of occupancy of D2-like receptor despite a common lack of extrapyramidal side-effects.

Original languageEnglish
Pages (from-to)355-365
Number of pages11
JournalJournal of Psychopharmacology
Volume18
Issue number3
DOIs
Publication statusPublished - Sep 2004

Fingerprint

olanzapine
Clozapine
Positron-Emission Tomography
Antipsychotic Agents
Basal Ganglia
Spiperone
Pituitary Gland
Therapeutics

Keywords

  • Basal ganglia
  • Clozapine
  • Emission tomography
  • Olanzapine
  • Pituitary
  • Receptor occupancy

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Cerebral D2 and 5-HT2 receptor occupancy in schizophrenic patients treated with olanzapine or clozapine. / Moresco, Rosa Maria; Cavallaro, Roberto; Messa, Cristina; Bravi, Daniele; Gobbo, Clara; Galli, Laura; Lucignani, Giovanni; Colombo, Cristina; Rizzo, Giovanna; Velonà, Isabella; Smeraldi, Enrico; Fazio, Ferruccio.

In: Journal of Psychopharmacology, Vol. 18, No. 3, 09.2004, p. 355-365.

Research output: Contribution to journalArticle

Moresco, RM, Cavallaro, R, Messa, C, Bravi, D, Gobbo, C, Galli, L, Lucignani, G, Colombo, C, Rizzo, G, Velonà, I, Smeraldi, E & Fazio, F 2004, 'Cerebral D2 and 5-HT2 receptor occupancy in schizophrenic patients treated with olanzapine or clozapine', Journal of Psychopharmacology, vol. 18, no. 3, pp. 355-365. https://doi.org/10.1177/026988110401800306
Moresco, Rosa Maria ; Cavallaro, Roberto ; Messa, Cristina ; Bravi, Daniele ; Gobbo, Clara ; Galli, Laura ; Lucignani, Giovanni ; Colombo, Cristina ; Rizzo, Giovanna ; Velonà, Isabella ; Smeraldi, Enrico ; Fazio, Ferruccio. / Cerebral D2 and 5-HT2 receptor occupancy in schizophrenic patients treated with olanzapine or clozapine. In: Journal of Psychopharmacology. 2004 ; Vol. 18, No. 3. pp. 355-365.
@article{e5b5ebfe11a8495e8a73f6f0b9a5a797,
title = "Cerebral D2 and 5-HT2 receptor occupancy in schizophrenic patients treated with olanzapine or clozapine",
abstract = "We report the results of a double-blind, randomized prospective trial on D2 and 5-HT2 receptor occupancy and the clinical effects of olanzapine versus clozapine in a sample of neuroleptic-refractory schizophrenic patients. Receptor occupancy was evaluated in different cortical areas and in basal ganglia using [18F]fluoro-ethyl-spiperone ([ 18F]FESP) and positron emission tomography (PET). A total of 15 neuroleptic-free patients completed the study undergoing a baseline and a post-treatment PET scan (olanzapine, nine patients, one female; clozapine, six patients, three female) 8 weeks after starting treatment. PET data were analysed both by regions of interest and on a voxel-by-voxel basis using Statistical Parametric Mapping (SPM96). Olanzapine and clozapine induced a similar and significant inhibition of [18F]FESP binding index in the cortex. In the basal ganglia, receptor occupancy was significantly higher with olanzapine than with clozapine (p = 0.0018). By contrast, no differences in receptor occupancy were detected at the level of the pituitary gland. Clinical outcomes, in particular a full extrapyramidal tolerability, were similar. In this sample of neuroleptic-refractory schizophrenic patients, olanzapine and clozapine showed a different pattern of occupancy of D2-like receptor despite a common lack of extrapyramidal side-effects.",
keywords = "Basal ganglia, Clozapine, Emission tomography, Olanzapine, Pituitary, Receptor occupancy",
author = "Moresco, {Rosa Maria} and Roberto Cavallaro and Cristina Messa and Daniele Bravi and Clara Gobbo and Laura Galli and Giovanni Lucignani and Cristina Colombo and Giovanna Rizzo and Isabella Velon{\`a} and Enrico Smeraldi and Ferruccio Fazio",
year = "2004",
month = "9",
doi = "10.1177/026988110401800306",
language = "English",
volume = "18",
pages = "355--365",
journal = "Journal of Psychopharmacology",
issn = "0269-8811",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Cerebral D2 and 5-HT2 receptor occupancy in schizophrenic patients treated with olanzapine or clozapine

AU - Moresco, Rosa Maria

AU - Cavallaro, Roberto

AU - Messa, Cristina

AU - Bravi, Daniele

AU - Gobbo, Clara

AU - Galli, Laura

AU - Lucignani, Giovanni

AU - Colombo, Cristina

AU - Rizzo, Giovanna

AU - Velonà, Isabella

AU - Smeraldi, Enrico

AU - Fazio, Ferruccio

PY - 2004/9

Y1 - 2004/9

N2 - We report the results of a double-blind, randomized prospective trial on D2 and 5-HT2 receptor occupancy and the clinical effects of olanzapine versus clozapine in a sample of neuroleptic-refractory schizophrenic patients. Receptor occupancy was evaluated in different cortical areas and in basal ganglia using [18F]fluoro-ethyl-spiperone ([ 18F]FESP) and positron emission tomography (PET). A total of 15 neuroleptic-free patients completed the study undergoing a baseline and a post-treatment PET scan (olanzapine, nine patients, one female; clozapine, six patients, three female) 8 weeks after starting treatment. PET data were analysed both by regions of interest and on a voxel-by-voxel basis using Statistical Parametric Mapping (SPM96). Olanzapine and clozapine induced a similar and significant inhibition of [18F]FESP binding index in the cortex. In the basal ganglia, receptor occupancy was significantly higher with olanzapine than with clozapine (p = 0.0018). By contrast, no differences in receptor occupancy were detected at the level of the pituitary gland. Clinical outcomes, in particular a full extrapyramidal tolerability, were similar. In this sample of neuroleptic-refractory schizophrenic patients, olanzapine and clozapine showed a different pattern of occupancy of D2-like receptor despite a common lack of extrapyramidal side-effects.

AB - We report the results of a double-blind, randomized prospective trial on D2 and 5-HT2 receptor occupancy and the clinical effects of olanzapine versus clozapine in a sample of neuroleptic-refractory schizophrenic patients. Receptor occupancy was evaluated in different cortical areas and in basal ganglia using [18F]fluoro-ethyl-spiperone ([ 18F]FESP) and positron emission tomography (PET). A total of 15 neuroleptic-free patients completed the study undergoing a baseline and a post-treatment PET scan (olanzapine, nine patients, one female; clozapine, six patients, three female) 8 weeks after starting treatment. PET data were analysed both by regions of interest and on a voxel-by-voxel basis using Statistical Parametric Mapping (SPM96). Olanzapine and clozapine induced a similar and significant inhibition of [18F]FESP binding index in the cortex. In the basal ganglia, receptor occupancy was significantly higher with olanzapine than with clozapine (p = 0.0018). By contrast, no differences in receptor occupancy were detected at the level of the pituitary gland. Clinical outcomes, in particular a full extrapyramidal tolerability, were similar. In this sample of neuroleptic-refractory schizophrenic patients, olanzapine and clozapine showed a different pattern of occupancy of D2-like receptor despite a common lack of extrapyramidal side-effects.

KW - Basal ganglia

KW - Clozapine

KW - Emission tomography

KW - Olanzapine

KW - Pituitary

KW - Receptor occupancy

UR - http://www.scopus.com/inward/record.url?scp=6044224985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6044224985&partnerID=8YFLogxK

U2 - 10.1177/026988110401800306

DO - 10.1177/026988110401800306

M3 - Article

C2 - 15358979

AN - SCOPUS:6044224985

VL - 18

SP - 355

EP - 365

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

SN - 0269-8811

IS - 3

ER -